Mammary gland involution is a physiological process in which the entire organ is remodeled through the process of apoptosis. Apoptosis of secretory alveolar cells is initiated at the time of weaning, followed by the collapse and disappearance of the entire lobuloalveolar compartment. While apoptotic figures were rare in mammary epithelium of lactating mice, their number increased after weaning and reached a maximum on day 3 of involution. Active cell death continued until day 5 after weaning and only little parenchyma remained on day 8, when remodeling of the gland was completed. Bax mRNA levels increased during the first day of involution independent of the presence or absence of p53. Bax protein was detected in an increasing number of cells after weaning, peaking at day 3 and decreasing thereafter. Low levels of bel-x mRNA and protein were present during lactation, followed by a sharp increase during the first 2 days of involution. The bel-xs splice variant of bel-x can promote cell death, and bel-XL has a protective function in cell culture. The ratio of bel-xs versus bel-XL remained stable in the virgin, pregnant and lactating gland. However, during the first 2 days of involution, bel-xs expression increased six-fold more than bel-XL' To further evaluate the role of Bel-xs which was less abundant in the mammary cells than Bel-XL, cotransfection studies were performed in cell culture. They confirmed that Bel-xs protein can facilitate apoptosis even when Bel-XL is present in excess. These findings point to a significant role for Bax and Bel-xs in the regulation of apoptosis of secretory alveolar cells during involution.
Introduction
A hallmark of the mammary gland is its regenerative capacity. In virgin mice, an organized system of ducts penetrates the mammary fat pad. Extensive ductal and lobulo-alveolar development mediated by lactogenic hormones and local growth regulators such as TGF-{H (for references see Kordon et aI., 1995) commences with each pregnancy and is completed at the onset of lactation. Development and functional differentiation of alveoli during pregnancy leads to the sequential expression of The transition from lactation to involution is accompanied by declining levels of systemic lactogenic hormones and the mammary gland transcription factor (MGF or Stat5), the rapid inactivation of milk protein genes, mild ischemia, and increasing intraluminal pressure, all of which may be involved in the induction of cell death and tissue remodeling (Silver, 1956; Ota et aI., 1962; Richards and Benson, 1971; Schmitt-Ney et aI., 1992) . At the same time the expression of genes possibly involved in tissue remodeling is induced (Dickson and Warburton, 1992; Lefebvre et aI., 1992; Strange et aI., 1992; Guenette et aI., 1994; Marti et aI., 1994; Boudreau et aI., 1995) . However, the trigger that decides whether individual epithelial cells will survive or undergo apoptosis is not known. Different cell types may utilize different pathways to undergo apoptosis depending on their developmental needs. For example, the lens and the choroid plexus develop just once, whereas mammary gland development is repeated with each pregnancy. While neither the lens nor the choroid plexus undergo extensive apoptosis during a lifespan, the entire alveolar compartment of the mammary gland is eliminated after weaning and the tissue is completely remodeled. This occurrence of fundamentally different developmental processes raises the question whether apoptosis pathways are shared between different cell types, or whether distinct pathways are used. Apoptosis in the choroid plexus (Symonds et aI., 1994) and the lens during early stages of development (Pan and Griep, 1996) is mediated through p53-dependent pathways. Only recently the concept has emerged that, depending on the cell type or the physiological condition, either p53-dependent or -independent pathways can be activated (Pan and Griep, 1996a; Li et aI., 1996a and references therein).
Bcl-2 promotes cell survival and is the prototype of a family of genes that regulate apoptosis (Hockenbery et aI., 1990; Oltvai et aI., 1993; Motoyama et aI., 1995; Takayama et aI., 1995; Yang et aI., 1995) . Deletion of the bcl-2 gene from the genome had no overt effects on embryogenesis (Veis et aI., 1993) . Their mammary glands develop normally, indicating that Bcl-2 does not playa dominant role in mammary gland remodeling. Bax shares 21 % amino acid sequence homology with Bcl-2 (Oltvai et aI., 1993) and has been shown to induce cell death in cell culture. Bax-deficient mice (Knudson et aI., 1995) display hyperplasia in their lymphoid system, supporting a role for Bax as a death-facilitating protein. The same animals, however, show enhanced cell death in their reproductive organs and exhibit aberrant mammary gland development (Korsmeyer, personal communication), creating a more complex picture of different functions Bax may fulfill in different cellular contexts. Two bcl-x mRNA splice variants exist, a long form, bcl-XL, encoding a protein that protects cells from death, and a short form, bcl-xs, that encodes a protein-promoting death (Boise et aI., 1993) . Mice lacking functional Bcl-x die during embryogenesis and massive cell death can be observed in the nervous system indicating a critical role for bcl-x in the developing organism (Motoyama et aI., 1995) .
Based on our study of SV40 T-antigen transgenic mice in which apoptosis can be induced precociously (Li et aI., 1996b) , it appears that both bcl-x and bax could be critical components of alveolar cell death and mammary gland remodeling during normal involution. To test this hypothesis we performed a detailed expression analysis of bax and bcl-x during normal involution of mammary tissue.
Results

Apoptosis of mammary epithelial cells
To investigate morphological and molecular changes during early stages of involution, pups were removed from their mothers at day 10 of lactation. The Tunel assay was used to identify dying cells containing fragmented DNA. During lactation, mammary tissue consisted of secretory alveoli and ducts with epithelial and myoepithelial cells embedded in fatty tissue. Only a few epithelial cells with fragmented DNA were detected (Fig. lA) . Twelve hours and 2 days after weaning, increasing numbers of cells underwent apoptosis (Fig. lB,C) ; some of them were shed into the alveolar lumina. The peak of apoptotic cell death was seen at day 3 after weaning, when remodeling of the mammary epithelium was most pronounced (Fig. ID) . Lobulo-alveolar structures became smaller, leading to an overall morphological change. On day 5 of involution alveoli were further reduced in number and size and apoptotic figures became less frequent (Fig. IE) . At day 8, regression of the gland was completed with few lobules and ducts remaining in the fatty tissue (Fig. IF) .
bcl-x and bax RNA levels in mammary alveolar cells increase during involution
The histological observations are indicative of massive cell loss by apoptosis during the first week after weaning. Underlying changes in the expression of the bax and bcl-x genes during involution were studied on Northern blots (Fig. 2) , in situ hybridization (Fig. 3) , Western blots (Fig.  4) and immunohistochemistry (Fig. 5) . Low levels of bclx mRNA were detected during lactation ( Fig. 2A ). Up to 12 h after weaning bcl-x mRNA expression was low, but increased after 24 h and remained high throughout involution. Similar to bcl-x, bax mRNA levels were low during lactation. Within 6 h after weaning, expression increased and stayed high until day 3 of involution. After day 3 the amount of bax mRNA declined (Fig. 2B) . In situ mRNA hybridization of bcl-x and bax showed weak and homogeneous labeling of epithelial cells during lactation (Fig. 3A,D) . One day after weaning label intensity had increased (Fig. 3B,E) , slowly leveling out later in involution, thereby confirming the Northern blot analysis (Fig.3C,F) .
Bax protein localizes to apoptotic mammary alveolar cells
Western blots and immunohistochemistry were performed to evaluate the presence of Bel-x and Bax protein.
Bax has a molecular weight of 21 kDa and was specifically recognized by an anti-bax peptide antibody (Fig. 4) . It was present throughout involution and its concentration increased late in involution. Bel-XL, which has a size of 30 kDa, was present at low levels during lactation, followed by an increase upon weaning (Fig. 4) . The decision whether or not a cell will undergo apoptosis may depend on the relative levels of each protein in an individual cell. Since Western blots can determine only the overall levels of bax or bcl-x within the tissue, we performed immuno-histochemistry to evaluate bax expression on a single cell level (Fig. S) . Homogeneous weak staining was observed during lactation ( Fig. SA) . At day 2 of involution increased staining of individual alveolar cells was observed (Fig. SB) . Some of these cells showed fragmented nuelei and were shed from the alveolar context into the lumen. The number of cells expressing high levels of bax increased at day 3 of involution ( Fig. SC) , as seen for the number of cells undergoing apoptosis as judged by the Tunel assay (Fig. ID) . Not all cells staining for bax were shed into the lumen, some remained part of collapsing alveoli ( Fig. SD) . At day 8 remodeling was almost completed. Some remaining cells of collapsed alveoli still exhibited strong bax staining, but no significant staining was observed in remodeled ductal structures (Fig. SF) .
Bax induction during involution is p53-independent
Miyashita and Reed (199S) reported that pS3 is a transcriptional activator of bax in human lung cancer cells. To test whether pS3 causes the induction of bax during mammary involution, we used mice lacking functional pS3. RNA isolated from mammary tissue of pS3 -/-mice was subjected to Northern blot analysis. During lactation only little bax mRNA expression was detected, followed by a 10-to SO-fold increase during the first 3 days after weaning, showing that the induction of bax expression is unchanged in the absence of pS3. At day 10 of involution no bax mRNA was detected.
bel-XL and bel-xs are differentially regulated
The bel-xL and bel-xs proteins are encoded by two different splice products and show opposing cellular functions. RT-PCR combined with differential hybridization was performed to distinguish between the bel-xL and belXs mRNA and their ratio was determined (Fig. 6 ). During lactation (as well as in virgin mice and during pregnancy, data not shown) the steady state level of bel-XL RNA was approximately 40-fold higher than that for bel-xs. Within the first 2 days of involution a transient six-fold increase in the ratio of bel-xs to bel-xL was observed. The relative increase of bel-xs was observed at 12 h after weaning, reached a maximum after 48 h, and decreased thereafter (Fig. 6 ).
The presence of bel-xs leads to loss of cell viability
To test whether a relative increase of Bel-xs over Bel-XL can cause cell death, we transfected a murine IL-3-dependent pro B-cell line with an expression vector encoding bel-xL or with expression vectors encoding both the long and short form. Apoptosis was induced by treatment with etoposide or IL-3 withdrawal. In vector transfected control cultures 98% or 100% of the cells underwent apoptosis after 4 days of etoposide treatment or IL-3 withdrawal, respectively. Expression of Bel-XL alone resulted in enhanced cell viability and only 27% of the cells died. Coexpression of Bcl-XL and Bel-xs resulted in an inhibition of the protective effect of Bel-xL' In these cultures 80% of the cells died by apoptosis after 4 days of etoposide treatment (Fig. 7 A) and S3% of the cells died after IL-3 withdrawal (Fig. 7B ). 
Discussion
Genes involved in apoptosis have been studied in cell culture (Hockenbery et aI., 1990; Boise et aI., 1993; Oltvai et aI., 1993; Yonish-Rouach et aI., 1993; Miyashita and Reed, 1995) , in transgenic mice (Li et aI., 1994) and in mice devoid of these genes (Donehower et aI., 1992; Veis et aI., 1993; Motoyama et aI., 1995) . However, at this point it is not clear which proteins mediate apoptosis during mammary gland remodeling. We now show that the expression pattern of two apoptosis genes, bax and bcl-x, parallels the timecourse of apoptosis during mam- mary gland involution. bel-xs and bax mRNA levels in mammary epithelial cells increase within the first day after weaning, coinciding with the induction of apoptosis. Increased amounts of Bax protein are found in apoptotic alveolar cells which are being shed from collapsing and remodeled alveoli. These results are a strong indication that both Bax and BeI-xs play an important role in the apoptosis of mammary alveolar cells during involution. The p53 tumor-suppressor has been linked to apoptosis in cell culture. Ectopic expression of p53 targeted to mammary tissue of pregnant mice results in a massive loss of alveolar cells (Li et aI., 1994) , suggesting that this molecule has the ability to induce apoptosis in the context of the whole animal. The mechanism of induction may be the upregulation of bax transcription, as shown in transfection studies in murine leukemia and human lung cancer cells (Selvakumaran et aI., 1994; Miyashita and Reed, 1995) . However, the strong induction of bax mRNA during the first 3 days of mammary gland involution is unchanged in animals lacking p53. Furthermore, we have recently demonstrated that apoptosis during normal involution (Li et aI., 1996a) and oncoproteininduced apoptosis during pregnancy is independent of functional p53 (Li et aI., 1996b) . This strongly suggests that p53-independent apoptosis pathways are used in the mammary gland.
Members of the bel-2 family of genes mediate apoptosis by forming homo-and heterodimers (Sedlak et aI., 1995) and the relative levels of each protein in an individual cell may determine whether or not a cell will undergo apoptosis (Oltvai and Korsmeyer, 1994) . BeI-2, the prototype of the bel-2 family, does not appear to playa dominant role in mammary gland involution.
Expression of the bel-2 gene during lactation and involution was very low and constitutive (unpublished observation), and mammary development is unaltered in bel-2 null mice (Veis et aI., 1993) . In contrast, bel-x and bax, which are elosely related to bel-2, exhibit features compatible with a critical role in apoptosis during mammary tissue remodeling. We originally observed that elevated levels of these molecules coincided with oncoproteininduced apoptosis of mammary alveolar cells in pregnant transgenic mice expressing the SV40 T-antigen under control of the W AP gene promoter (Li et aI., 1996b ). We now demonstrate that a transient induction of these proteins occurs also during alveolar apoptosis in the normal involution process following weaning. BeI-x can be transcribed and processed into two different RNA forms with opposing functions (Boise et aI., 1993) . Bel-xL is the more abundant form and inhibits apoptosis. BeI-xs is expressed at lower levels and accelerates cell death in cell transfection studies. Because of its lower expression levels, the role of bel-xs in promoting apoptosis under physiological conditions has not been obvious. Gonzalez-Garcia and coworkers have analyzed bel-x expression in several organs during embryonic development and in the adult organism (but not in mammary tissue) and did not detect bel-xs, arguing against a widespread role of bel-xs during development (Gonzalez-Garcia et aI., 1994). In the mammary gland, however, bel-xs mRNA is present.
The expression pattern of the bel-x and bax genes during lactation and involution, in conjunction with the increase of the bel-xs mRNA shortly after weaning, supports a role for these proteins in apoptosis during remodeling of mammary tissue. The expression pattern of BeI-x protein followed elosely the expression of the RNA. While bax mRNA was induced in early involution and decreased after day 3, Bax protein levels did not change significantly up to day 5 and increased thereafter. The disappearance of bax mRNA 3 days after weaning could be explained by RNA degradation in dying cells. The protein may be more stable, an assumption that is supported by the appearance of large cells in the alveolar lumina that stain heavily for Bax protein and may represent macrophages with engulfed cell debris. The reported half-life for Bax is cell type-dependent and can be longer than 24 h (Miyashita et aI., 1996) . In immunohistochemistry strong expression of Bax protein was seen in dying cells, elearly demonstrating a correlation between the presence of Bax and apoptosis. By biochemical and morphological criteria, the peak of cell death was observed 3 days after weaning. Cell culture studies have demonstrated that human bel-xs and bax expression sensitizes cells to cell death signals, probably by inhibiting the ability of bel-2 to promote cell survival. Cells die within 24-48h (Boise et aI., 1993; Oltvai et aI., 1993) . In mammary gland, the increase of steady state levels of belXs and bax mRNA preceded apoptosis by 24-48 h, thus temporally coinciding with the decision of alveolar cells to undergo apoptosis. Interestingly, even at the height of apoptosis the bel-xs mRNA seems to be less abundant than bel-XL mRNA. This is in agreement with our cell culture studies in which bel-xs can increase the apoptosis rate in cells in the presence of a three-fold excess of bel-XL' Similarly, bel-xs can facilitate apoptosis in a human breast cancer cell line expressing excess bel-xL (Sumantran et aI., 1995) . These experiments demonstrate that small changes in bel-xs levels can affect cell viability. The correlation between the number of apoptotic cells detected by histology and the ratio of bel-xs versus bel-XL suggests that the induction of bel-xs may occur in only a few cells which proceed into apoptosis. The ratio of molecules which function to repress cell death (Bcl-2 and Bel-XL) to those promoting apoptosis (Bax and Bel-xs) may represent a cell-autonomous rheostat that determines a cell's response to an apoptotic stimulus (Oltvai et aI., 1993; Sato et aI., 1994; Yang et aI., 1995) . 4. Material and methods
Mice
C57BLl6 wildtype and 129 p53 null females were used for these studies. The mice that contained two defective germ-line p53 alleles carried a targeted disruption of the p53 gene (The Jackson Laboratory, Bar Harbor, ME) (Jacks et aI., 1994) .
Tunel assay
Mammary gland specimens were fixed in 4% paraformaldehyde in PBS and embedded in paraffin by standard methods. Sections (5.um) were mounted on silan-coated slides. Apoptotic cell nuclei were identified using the ApopTag kit (Oncor, Gaithersburg, MD). Sections were initially treated with 20.ug/ml proteinase K in PBS for 15 min at room temperature, quenched by 0.0003% H 2 0 2 for 30 min at room temperature, equilibrated with buffer, incubated with TdT for 20-40 min at room temperature, washed with wash stop buffer for 30 min at 37°C, and incubated with anti-digoxigenin for 30 min at room temperature. Color was developed using 0.05% 3,3'dimethylaminoazobenzene, 0.01% H 2 0 2 diluted in 0.1 M Tris-HCI (pH 7.5) and counterstained with methyl green. 
Northern blot analysis
RNA was prepared according to Chomczynski and Sacchi (1987) . Electrophoresis of RNA was performed using the formaldehyde method (Sambrook et aI., 1989) ; 20 flg of total RNA were used per lane. The RNA was transferred to nylon membranes (GeneScreen Plus). To estimate the amount of RNA on the membrane, RNA was stained with methylene blue (Herrin and Schmidt, 1988) . The filters were hybridized with probes described below and washed using standard protocols.
In situ hybridization
Mammary gland tissue was embedded in Miles embedding medium and frozen on dry ice. Sections (12-16 flm) were mounted on silan-coated slides and used for in situ hybridization. Sections were fixed in 4% paraformaldehyde in PBS, treated with 2 flg/ml proteinase K for 10 min at room temperature, post-fixed in 4% paraformaldehyde and acetylated. After prehybridization in 0.3 M NaCl, 20 mM Na-acetate (pH 5), 5 mM EDTA, 50% formamide, 10% Dextran sulfate, I X Denhardt's solution, 100 mM DTI, plus 80 flglfll yeast tRNA for 2-3 h, 35S-labeled cRNA probes were hybridized overnight at 45°C in the same solution using ca. 3 X 10 7 cpmlmi. Sections were washed in 4 X SSC, 10 mM DTI, at RT (4 X 15 min) and treated with 20 flg/ml RNaseA in 0.5 M NaCl, 10 mM Tris-HCl (pH 8),1 mM EDTA, at 37°C for 30 min. Further washes were performed in 0.5 M NaCl, 10 mM Tris-HCl (pH 8), 1 mM EDTA, 10 mM {3-mercaptoethanol at 37°C (4 X 10 min), 2 X SSC, 10 mM {3-mercaptoethanol at 37°C (4 X 15 min), and 15 min in 0.1 X SSC, 10 mM {3-mercaptoethanol at 50°C. Sections were dried and dipped in Kodak NTB-2 emulsion, 600 mM NH 4 -acetate, exposed at 40°C for 1 week and developed in Kodak D-19.
Probes for hybridization
To generate a probe specific for mouse bcl-x, we used partially degenerate primers from conserved stretches of human and chicken cDNA. PCR amplification of mouse genomic DNA with the primer pair ACCGGGAGc/tTaI gGTGalgTIGACTTT and GGGGTGATGTGGAGCTG-GGA resulted in a DNA fragment of 334 bp. RT-PCR was performed to generate a mouse bax probe from total RNA of a mammary gland 1 day after weaning. The primer pair CTIGGAGCAGCCGCCCCAGG and GG-CACTTTAGTGCACAGGGC amplified a fragment of 260 bp. Both fragments were cloned into the vector pCRTMII (Invitrogen). Sequencing proved that the clones were identical to the corresponding regions of the published bcl-x (Gonzalez-Garcia et aI., 1994) and bax mouse sequences (Oltvai and Korsmeyer, 1994) For Northern hybridization the inserts were isolated and labeled with 32p by random prime labeling (Stratagen). For in situ hybridization 35S-labeled RNA probes were generated by transcription of linearized plasmids (Boehringer).
RT peR and DNA hybridization
For RT-PCR 1 flg total RNA was reverse transcribed in 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCI 2 , 125 flM each ATP, CTP, GTP, and TIP, 10 mM DTI, 2 flM specific primer (CA TGCCCGTCAGGAACCAG-CGG), reading upstream, and 200 U MLV RT (Gibco). Half of the RT product was used in a 50 fll PCR reaction. Using an annealing temperature of 65°C, 25 cycles of PCR were performed in 25 mM Tris-HCl (pH 8.3), 40 mM KCl, 2 mM MgCI 2 , 50flM each ATP, CTP, GTP, and TIP, O.ot % gelatin, 0.4 flM both specific primers (downstream primer: GCGCGGGAGGTGATICCCAT-GGC), and 1.5 U Taq polymerase (Promega). PCR products were separated on a 1.2% agarose gel, denatured and blotted on nylon membranes (Gene Screen Plus). The UV crosslinked DNA was hybridized to [a 32 p] end-labeled specific oligonucleotides (CGCTTTCCACGCACAGTG-CCCCGCC for bcl-XL and CAGAGCTTTGAGCAGGA-CACTTTTGTGG for bcl-xs, spanning the region of the splice site) at 60°C in 0.4 M NaCl, 1 % SDS, 5 X Denhardt's solution, and 100 flg/ml salmon sperm DNA for 12-18 h. Membranes were washed in 2 X SSC, 0.1 % SDS at 60°C and 65°C. The resulting signals were quantitated using a phosphoImager (Molecular Dynamics).
Western blot analysis
Total cell lysate was prepared from mammary tissue and thymus using RIPA (1 % NP40, 0.5% sodium deoxycholate, 0.1 % SDS in PBS). Proteinase inhibitors PMSF, aprotinin and sodium orthovanadate were added. Protein (50 flg) was fractionated in a SDS-14% polyacrylamide gel and transferred to PVDF membranes (Novex). After blocking in 5% non-fat milk in T-PBS (0.1 % Tween 20, 10 mM Tris-HCl (pH 7.5), 0.1 M NaCl) for 1 h at room temperature, the membranes were incubated in 0.5 flg/ml anti-bax antibody (N20) or anti-bcl-x antibody (S18) (Santa Cruz Biotechnology) in blocking buffer for 1 h at room temperature, washed in T-PBS, and incubated in a 1 :4000 dilution of peroxidase-conjugated goat anti-rabbit IgG polyclonal antibody (Sigma Immunochemicals) for 1 h at room temperature. Totallysates from FL5.12 cells were prepared by lysing cells in 1 % SDSIPBS. Lysates were boiled for 10 min, sonicated, and microfuged to remove debris. Lysates from 2 X 10 6 cells were boiled in 2 X sample buffer, run on a 14% polyacrylamide/SDS gel, and transferred onto a 0.2 flm PVDF membrane. The blot was incubated with a 1 :5000 dilution of a monoclonal anti-human Bcl-x antibody (courtesy of Dr. Craig Thompson), washed, and incubated with a 1 :50 000 dilu-tion of goat anti-mouse IgG Fc-HRP antibody (Jackson Immunoresearch). The ECL Western blotting kit (Amersham) was used for detection. As a loading control, filters were stained with Poncean stain (Daitbother) or gels were stained with Coomassie blue (Novex).
Immunohistochemistry
Paraffin sections were deparaffinized, treated with 2,ug/ml of proteinase K in PBS for 10 min, and quenched in 0.3% H 2 0 2 in PBS for 15 min. Pretreatment with 10% goat serum, and 0.1 % BSA in PBS was followed by an incubation in 0.5,ug/ml anti-bax antibody in the same buffer for 1 h at room temperature. The Vectastain Elite ABC kit (Vector) was used for detection according to manufacturers protocol. The color reaction was performed in Sigma Fast DAB reagent (Sigma).
Cell culture
The murine IL-3-dependent pro B-celliine FL5.12 was maintained in RPMI (Gibco, Grand Island, NY) supplemented with 10% FCS, and 10% WEHI-3B (D-)-conditional medium as a source of IL-3 as described (Nunez et aI., 1990) .
Transfection of cells
An eight amino-acid Flag epitope tag (Hopp et aI., 1988 ) and a ten amino-acid HA epitope (Kolodziej and Young, 1991) were attached by PCR to the N-termini of human Bcl-xL or Bcl-xs, respectively. The FL5.12 murine pre-B cell line was singly transfected with 20,ug of pSFFVneo Bcl-xL Flag or pSFFVneo Bel-xs HA, or was co-transfected with 10,ug of each plasmid by electroporation (200 V, 960,uF) . Cells were plated at 5000 cells/well, and stably transfected clones were selected for neomycin resistance by growth in 2 mg/ ml G418 (Gibco). Surviving clones were screened for expression of either Bcl-xL Flag, Bcl-xs HA or both by Western blotting and Flow cytometric analysis using the Flag M2 antibody (lEI) or anti-HA monoclonal 12CA5 (Boehringer Mannheim). Single Bel-XL Flag, single BelXs HA, and double expressing clones were selected for further analysis. Apoptosis in cells treated with etoposide or IL-3 withdrawal was measured by propidium iodide staining as previously described (Grillot et aI., 1995) .
